NeuroPace, Inc.
NPCE
$15.96
$0.332.11%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 99.53M | 99.99M | 94.86M | 88.57M | 84.31M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 99.53M | 99.99M | 94.86M | 88.57M | 84.31M |
| Cost of Revenue | 21.60M | 22.77M | 22.03M | 21.49M | 21.22M |
| Gross Profit | 77.93M | 77.22M | 72.83M | 67.08M | 63.08M |
| SG&A Expenses | 67.05M | 65.67M | 64.14M | 60.86M | 57.05M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 116.29M | 116.32M | 113.09M | 108.44M | 103.58M |
| Operating Income | -16.76M | -16.34M | -18.22M | -19.87M | -19.27M |
| Income Before Tax | -21.57M | -21.47M | -23.99M | -25.94M | -24.81M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -21.57 | -21.47 | -23.99 | -25.94 | -24.81 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.57M | -21.47M | -23.99M | -25.94M | -24.81M |
| EBIT | -16.76M | -16.34M | -18.22M | -19.87M | -19.27M |
| EBITDA | -16.51M | -16.10M | -18.02M | -19.66M | -19.06M |
| EPS Basic | -0.65 | -0.66 | -0.75 | -0.83 | -0.83 |
| Normalized Basic EPS | -0.41 | -0.41 | -0.48 | -0.53 | -0.52 |
| EPS Diluted | -0.65 | -0.66 | -0.75 | -0.83 | -0.83 |
| Normalized Diluted EPS | -0.41 | -0.41 | -0.48 | -0.53 | -0.52 |
| Average Basic Shares Outstanding | 133.10M | 130.86M | 127.39M | 123.70M | 119.69M |
| Average Diluted Shares Outstanding | 133.10M | 130.86M | 127.39M | 123.70M | 119.69M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |